Health and Fitness Health and Fitness
Thu, December 1, 2011
Wed, November 30, 2011
[ Wed, Nov 30th 2011 ] - Market Wire
Watson Launches Generic LIPITOR
Tue, November 29, 2011
Mon, November 28, 2011
Sun, November 27, 2011
Fri, November 25, 2011
Thu, November 24, 2011
Wed, November 23, 2011
[ Wed, Nov 23rd 2011 ] - Market Wire
00 a.m. EST
Tue, November 22, 2011
[ Tue, Nov 22nd 2011 ] - Market Wire
BD Board Increases Dividend
Mon, November 21, 2011
Sun, November 20, 2011
Fri, November 18, 2011
Thu, November 17, 2011

ShangPharma to Attend Two Upcoming Investor Conferences


//health-fitness.news-articles.net/content/2011/ .. to-attend-two-upcoming-investor-conferences.html
Published in Health and Fitness on Monday, November 28th 2011 at 2:41 GMT by Market Wire   Print publication without navigation


ShangPharma to Attend Two Upcoming Investor Conferences -- SHANGHAI, Nov. 28, 2011 /PRNewswire-Asia/ --

ShangPharma to Attend Two Upcoming Investor Conferences

[ ]

SHANGHAI, Nov. 28, 2011 /PRNewswire-Asia/ -- ShangPharma Corporation (NYSE: [ SHP ]) ("ShangPharma" or the "Company"), a leading China-based pharmaceutical and biotechnology research and development outsourcing company, today announced that it is scheduled to present at the following investor conferences in December 2011:

Ms. Lan Xie, Vice President of Finance and Investor Relations of ShangPharma, will present at the following conferences:

  • Deutsche Bank 5th Annual MedTools Investor Summit, December 5-6, 2011, Boston
  • Oppenheimer 22nd Annual Healthcare Conference, December 13-14, 2011, New York City

Presentation materials will be available under the Webcasts & Presentations section of the Company's investor relations website at [ http://ir.shangpharma.com ].

ABOUT SHANGPHARMA CORPORATION

ShangPharma Corporation (NYSE: [ SHP ]) is a leading China-based contract research organization providing high quality and cost-effective services for the pharmaceutical and biotechnology industry. It offers a broad range of high-quality, integrated services across the drug discovery and development process to help international and Chinese pharmaceutical and biotechnology companies discover and develop novel drug candidates efficiently. ShangPharma's services consist of discovery chemistry, discovery biology and preclinical development, pharmaceutical development and biologics services. For more information, please visit [ www.shangpharma.com ].

For further information, please contact:  

ShangPharma

Ms. Lan Xie

VP of Finance and Investor Relations

Email: [ ir@shangpharma.com ]


Brunswick Group

Lilian Wong

Email: [ shangpharma@brunswickgroup.com ]

Phone: 86-10-5960-8600



SOURCE ShangPharma Corporation

[ Back to top ]

RELATED LINKS
[ www.shangpharma.com ]
[ http://ir.shangpharma.com ]


Publication Contributing Sources